We conclude that the increased phosphorylation/activity of MAPKAPK2 observed in PME-1-high-expressing GBM cells is, therefore, causally linked to the increased sensitivity of these cells to oxidative stress. This evidence concerns the gene MAPKAPK2 and glioblastoma.